TrialAmerican journal of hematology2019

A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.

Mark R Litzow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.